510(k) Report

510(k) · Cleared

Cleared

Mda Heparin Anti-X Assay

K965076510(k) TraditionalCleared Mar 18, 199789-day reviewClass II21 CFR 864.7525

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Organon Teknika Corp. · KFF Assay, Heparin

Cleared on Mar 18, 1997 as substantially equivalent to K925433 (American Bioproducts Co., 1995) after an 89-day review. Its family tree reaches back 1 generation to 1995.

Decided
Mar 18, 1997
Review
89 days
Class
Class II
Product code
KFF
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K925433 (1995). No later device cites it as a predicate yet.

K925433 · The Stachrom Heparin Assay Kit · American Bioproducts Co. · 199519961998
  1. Root · 1 generation backK925433 The Stachrom Heparin Assay KitAmerican Bioproducts Co. · 1995
  2. This deviceK965076 Mda Heparin Anti-X AssayOrganon Teknika Corp. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K925433The Stachrom Heparin Assay KitAmerican Bioproducts Co.1995—
0 (this device)K965076Mda Heparin Anti-X AssayOrganon Teknika Corp.1997—
FIG. 1 — Lineage of K965076, 1995–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KFF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KFF device

  1. #1 K260214 STA® - Liquid Anti-Xascore 12.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K925433The Stachrom Heparin Assay Kit
Summary page 1
…Heparin assay (a) (3) An identification of the legally marketed device to which the submitter claims substantial equivalence, Device Equivalent to: Stachrom® Heparin (K925433) (a) (4) A description of the device(System) Description of MDA Heparin anti-Xa Heparin is administered to prevent thrombotic…
American Bioproducts Co.1995—

Also cleared against K925433: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K925433.

How does its category compare?

All KFF devices

KFF Assay, Heparin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KFF

1in 2022

2009: 12011: 12017: 12022: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KFF

Too few KFF 510(k)s in any year since 2007 to give a median.

Recalls per year · KFF

1in 2024

2010: 12021: 12024: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KFF

7in 2025

2007: 12013: 42014: 32017: 42018: 52019: 12021: 42022: 12025: 7
2007high 7 (2025) · low 0 (2008)2025

MAUDE reports naming product code KFF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—01
20080—00
20091—00
20100—10
20111—00
20120—00
20130—04
20140—03
20150—00
20160—00
20171—04
20180—05
20190—01
20200—00
20210—14
20221—01
20230—00
20240—10
20250—07
20261—0—

What is it indicated for?

MDA™ Heparin anti-Xₐ is a chromogenic assay for the quantitative determination of heparin anti-Xₐ activity in human plasma.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K965076: Mda Heparin Anti-X Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K965076

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026